Insomnia in the context of cancer: A review of a neglected problem

Journal of Clinical Oncology

Volumn 19, Issue 3, 2001, Pages 895-908

  Savard, J ^a   Morin, C M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOBARBITAL; BROMAZEPAM; CLONAZEPAM; ESTAZOLAM; FLURAZEPAM; LORAZEPAM; NITRAZEPAM; OXAZEPAM; PENTOBARBITAL; QUAZEPAM; SECOBARBITAL; TEMAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

BEHAVIOR DISORDER; CANCER; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE ASSOCIATION; HUMAN; HYPNOSIS; INSOMNIA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RATING SCALE; REVIEW;

EID: 0035253747     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.3.895     Document Type: Review

References (122)

1. Sleep alterations in cancer patients
2. Insomnia in cancer patients
3. Management of sleep problems in cancer patients
4. A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy
5. Psychological reactions in patients with malignant melanoma
6. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy
7. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer
8. Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer
9. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
10. Sleep patterns in patients with cancer and patients with cardiac disease
11. Symptoms of pancreatic cancer
12. Loss of physical functioning among patients with cancer
13. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer
14. Assessment of the impact of cancer on work, recreation, home, management and sleep using a general health status measure
15. Comparison of subjective sleep quality in patients with cancer and healthy subjects
16. Symptom prevalence, characteristics and distress in cancer population
17. Correlates of symptom distress in women with lung cancer
18. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention?
19. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction
20. Case studies in insomnia
21. Sleep and psychopathology
22. Depressive disorders
23. Anxiety disorders
24. Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980
25. Why do we need sleep? Relating theory to nursing practice
26. Surgery
27. Determinants of the psycho-social outcome after operation for breast cancer: Results of a prospective comparative interview study following mastectomy and breast conservation
28. Sleep disturbances in hospitalized patients with cancer
29. Chemotherapy, hormonal therapy, and immunotherapy
30. Evaluation of symptom distress in a bone marrow transplant outpatient environment
31. Effect of postchemotherapy nausea and vomiting on health-related quality of life
32. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy
33. Side effects of corticosteroid therapy: Psychiatric aspects
34. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as antiemetics for cancer chemotherapy
35. Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy
36. Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin
37. Natural menopause and ovarian toxicity associated with breast cancer therapy
38. A randomized clinical trial evaluating tamoxifen in the treatment of patients with nodenegative breast cancer who have estrogen-receptor-positive tumors
39. Symptoms associated with tamoxifen treatment in postmenopausal women
40. Hormonal therapies
41. Genitourinary malignancies
42. Association of waking episodes with menopausal hot flushes
43. The association between mid-sleep waking episodes and hot flushes in post-menopausal women
44. Sleep patterns and stability in perimenopausal women
45. The thermoregulatory effects of menopausal hot flashes on sleep
46. When does estrogen replacement therapy improve sleep quality?
47. Effects of estrogens on sleep and psychological state of hypogonadal women
48. Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors
49. Control of pain in cancer patients
50. Pain in ambulatory patients with lung or colon cancer
51. Pain syndromes associated with cancer
52. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic
53. Cancer pain management: A recent experience by anaesthesiologists in a teaching hospital in Hong Kong
54. Pain experience and pain management among hospitalized cancer patients: A clinical study
55. Emotional and social aspects of cancer pain
56. Occurrence, causes, and outcome of delirium patients with advanced cancer: A prospective study
57. Delirium
58. Fatigue-reducing strategies used by patients receiving treatment for cancer
59. Fatigue in women with breast cancer receiving radiation therapy
60. Self-care behaviours initiated by chemotherapy patients in response to fatigue
61. Cognitive therapy
62. Fatigue and sleep disorders
63. Fatigue
64. Cancer-related fatigue: Guidelines for evaluation and management
65. Fatigue in patients with cancer
66. Fatigue and the cancer experience: The state of knowledge
67. Fatigue and its associated factors in ambulatory cancer patients: A preliminary study
68. Off-treatment fatigue in breast cancer survivors: A controlled comparison
69. Fatigue and radiotherapy: (B) Experience in patients 9 months following treatment
70. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer
71. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: A comparison with the fatigue experienced by healthy individuals
72. Fatigue and radiotherapy: (A) Experience in patients undergoing treatment
73. Neuropsychological performance in elderly insomnia patients
74. Cognitive deficits in insomnia patients
75. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults
76. Insomnia in young men and subsequent depression
77. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders?
78. Does sleep disturbance predict depression in elderly people? A study in inner London
79. The morbidity of insomnia uncomplicated by psychiatric disorders
80. Somatic diseases and sleep complaints: An epidemiological study of 3201 Swedish men
81. Prevalence, burden, and treatment of insomnia in primary care
82. Biopsychobehavioral correlates of insomnia. V: Clinical characteristics and behavioral correlates
83. Insomnia and its treatment: Prevalence and correlates
84. Short and long sleep and sleeping pills: Is increased mortality associated?
85. Mortality risk associated with sleeping patterns among adults
86. Health practices and cancer mortality among active California Mormons
87. Sleep deprivation and human immune function
88. Sleep deprivation and the immune system
89. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects
90. Immunity and depression: Insomnia, retardation, and reduction of natural killer cell activity
91. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer
92. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
93. A survey of psychotropic drug prescriptions in an oncology population
94. Management of insomnia
95. Benzodiazepines and zoipidem for chronic insomnia: A meta-analysis of treatment efficacy
96. Polysomnographic effects of hypnotic drugs: A review
97. A review of the safety profiles of benzodiazepine hypnotics
98. Psychological and pharmacological treatments for insomnia
99. Meta-analysis of benzodiazepine use in the treatment of insomnia
100. Taking policy action to reduce benzodiazepine use and promote self-care among seniors
101. Sedative-hypnotics and human performance
102. Benzodiazepines of long and short elimination half-life and the risk of hip fracture
103. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients
104. Drug-induced cognition disorders in the elderly: Incidence prevention and management
105. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly
106. Drugs and insomnia: The use of medication to promote sleep
107. Consensus development conference statement: The treatment of sleep disorders of older people
108. NIH releases statement on behavioral and relaxation approaches for chronic pain and insomnia
109. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy
110. Identifying effective psychological treatments for insomnia: A meta-analysis
111. The treatment of severe insomnia in a cancer patient
112. Treatment of insomnia in cancer patients using muscle relaxation training
113. Preliminary results of a randomized trial on the efficacy of cognitive-behavioral treatment for insomnia in breast cancer
114. Sleep disorders: Evaluation and diagnosis
115. Stimulus-control: Nonpharmacologic treatment for insomnia
116. Stimulus control techniques for sleep onset insomnia
117. Self-help treatment for insomnia: Bibliotherapy with and without professional guidance